STAAR Surgical (STAA) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
STAAR Surgical Reports First Quarter 2015 Results
April 29, 2015 4:01 PM EDTMONROVIA, Calif., April 29, 2015 /PRNewswire/ --Â STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today reported financial results for the first quarter ended April 3, 2015.
First Quarter Overview
Net Sales of $18.9 Million Decreased 7% from the Year Ago Period and 3% on a Constant Currency Basis ICL Units in North America Increased 18% and EMEA Units Increased 9% CentraFLOW® Accounted for 78% of ICL Shipments in China Gross Margin Increased to 68% in Q1 vs. 57% in Q4 2014... More